CuraVac
↗Rixensart, Belgium
CuraVac is a clinical-stage biotechnology company developing Targeted Active Therapy and Active Targeted Immunotherapies for autoimmune diseases using a revolutionary technique based on complementary peptides. Founded in 2002 by Dr. Stéphane Huberty, a Belgian medical doctor with myasthenia gravis, the company aims to treat and induce long-term immunity against autoimmune diseases including Multiple Sclerosis (MS), Myasthenia Gravis (MG), Type 1 diabetes, Graves' disease, Systemic Lupus Erythematosus (SLE), and Hashimoto's disease. The company operates as a Belgian operating subsidiary coordinating clinical studies and development of its immunotherapy pipeline.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Immunotherapy | Therapeutic Vaccines
SIZE & FINANCIALS
Employees:1-50
Founded:2002
Ownership:private
Status:operating
FUNDING
Stage:Clinical Stage
Total Raised:$2.4M
PIPELINE
Stage:Phase 1B (completed) | Phase 2 (in preparation)
Lead Drug Stage:Phase 2 preparation
Modalities:Therapeutic Vaccine, Complementary Peptides, Targeted Active Therapy, Immunotherapy
Active Trials:0
Trial Phases:Phase 1: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Antwerp University Hospital (UZA) - Phase 1B clinical trial site, Wallonia Public Service (SPW) - Technology R&D support for CV-MG02 development, Professor J. Edwin Blalock - Scientific advisor and original discoverer of Targeted Active Immunotherapy technology
COMPETITION
Position:Niche Player
Competitors:Neurochem Pharma, Annexon Biosciences, Cabaletta Bio, iTeos Therapeutics, Jounce Therapeutics
LEADERSHIP
Key Executives:
Dr. Stéphane Huberty - Founder & CEO
Nicolas Havelange - Chief Operating Officer
Matthieu André - Chief Financial Officer
Scientific Founders:Dr. Stéphane Huberty, Professor J. Edwin Blalock
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with CuraVac. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.